Understanding and Applying Updated FDA Guidance
Posted: 4 December 2024 | West Pharmaceutical Services | No comments yet
Understanding and Applying the Updated FDA Guidance: Inspection of Injectable Products for Visible Particulates.
The growth of injectable products is driving efforts to tighten the control of particulate matter in pharmaceuticals. This white paper will discuss particulate risks, potential sources, and approaches to control particulates in injectables and review the draft regulatory guidance on the inspection of injectable products for visible particulates meet many of today’s manufacturing requirements.
